Canada (CA)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The Minimum Patient Acceptable Symptom State for the ACL-Return to Sport after Injury Scale Among Patients Treated With Anterior Cruciate Ligament Reconstruction. (2025) Dwyer T, Ajrawat P, Lameire DL, Betsch M, Whelan D, Shahrokhi S, Theodoropoulos J, et al. Journal article Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease. (2025) Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, Hauske SJ, Emberson JR, et al. Journal article Depressive Symptoms and Amyloid Pathology (2025) Wiels WA, Oomens JE, Engelborghs S, Baeken C, Von Arnim CA, Boada M, Didic M, et al. Journal article Non-Inferiority Trials in Stroke Research: What Are They, and How Should We Interpret Them? (2025) Li L, Lioutas VA, Akyea RK, Gerner S, Lau KK, Ramage E, Katsanos AH, et al. Journal article, Review article Supernova remnants on the outskirts of the Large Magellanic Cloud (2025) Sasaki M, Zangrandi F, Filipović M, Alsaberi RZ, Collier JD, Haberl F, Heywood I, et al. Journal article A HALF CENTURY OF THE SONOGASHIRA REACTION (2025) Frankenberger S, Wendinger D, Scherer A, Sonogashira K, Tykwinski RR, Hall DG, Charette A Book chapter / Article in edited volumes International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study. (2025) Caron AG, van Huizen AM, Musters AA, Gerbens LA, Middelkamp Hup MA, Flohr C, Irvine AD, et al. Journal article Efficient Codebook Design and User Scheduling for Large STAR-RIS-Aided Downlink URLLC Transmission (2025) Darabi M, Khalili A, Lampe L, Schober R Journal article Introducing the OECD guidance document on occupational biomonitoring: A harmonized methodology for deriving occupational biomonitoring levels (OBL) (2025) Hopf NB, Bessems J, Santonen T, Viegas S, Casteleyn L, Poddalgoda D, Lamkarkach F, et al. Journal article Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial (2025) Cardoso F, O’Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, et al. Journal article